Deferoxamine Mesylate Injection
Last Updated: March 23, 2016
Status: Resolved
Products Affected - Description
All presentations are currently available
Reason for the Shortage
- Fresenius Kabi has deferoxamine available.
- Hospira has deferoxamine available.
- Novartis discontinued Desferal 2 gram vials in 2015. The 500 mg vials are available.
- Teva discontinued all deferoxamine presentations in 2013.
- West-Ward discontinued deferoxamine in September 2014.
- Watson discontinued all deferoxamine presentations.
Available Products
Desferal injection, Novartis
500 mg, vial, 4 count (NDC 00078-0467-91)
2 gram, vial, 4 count (NDC 00409-2337-25)
Estimated Resupply Dates
All marketed presentations are available.
Related Shortages
- Calcium Disodium Versenate — Resolved
- Dimercaprol Injection — Resolved
Updated
March 23, January 20, 2016; December 3, November 17, September 25 and 2, August 4, July 20 and 10, May 8 and 6, March 23 and 13, February 24 and 4, January 14, 2015; December 15 and 3, October 24 and 8, September 3, August 8, July 14, 2014; August 5, May 17, March 11, February 5, January 7, 2013; December 10, November 27, October 22, September 27, August 3, June 5, April 23 and 4, March 20 and 8, February 16, January 25, 2012; December 22, October 27, September 20, August 25, June 30 and 2, May 11, March 17, January 24 and 6, 2011; December 3, November 9, October 11, September 28 and 8, August 24, 20 and 5, July 21 and 2, June 23, 2010, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.
